---
document_datetime: 2023-09-21 20:53:49
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/vazkepa-epar-all-authorised-presentations_en.pdf
document_name: vazkepa-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.8887565
conversion_datetime: 2025-12-25 06:52:36.496762
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented)   | Strength   | Pharmaceutical Form   | Route of       | Immediate Packaging    | Pack size                |
|------------------|--------------|------------|-----------------------|----------------|------------------------|--------------------------|
|                  | name         |            |                       | Administration |                        |                          |
| EU/1/20/1524/001 | Vazkepa      | 998 mg     | Capsule, soft         | Oral use       | bottle (HDPE)          | 120 capsules             |
| EU/1/20/1524/002 | Vazkepa      | 998 mg     | Capsule, soft         | Oral use       | blister (PVC/PCTFE/Al) | 4x2 capsules (unit dose) |
| EU/1/20/1524/003 | Vazkepa      | 998 mg     | Capsule, soft         | Oral use       | bottle (HDPE)          | 360 (3x120) capsules     |